Raphael Claire, Briscoe Cathy, Davies Justin, Ian Whinnett Zachary, Manisty Charlotte, Sutton Richard, Mayet Jamil, Francis Darrel P
Imperial College of Science Technology and Medicine, London, UK.
Heart. 2007 Apr;93(4):476-82. doi: 10.1136/hrt.2006.089656. Epub 2006 Sep 27.
Two ways to evaluate the symptoms of heart failure are the New York Heart Association (NYHA) classification and asking patients how far they can walk (walk distance). The NYHA system is commonly used, although it is not clear how individual clinicians apply it.
To investigate how useful these measures are to assess heart failure and whether other questions might be more helpful.
30 cardiologists were asked what questions they used when assessing patients with heart failure. To assess interoperator variability, two cardiologists assessed a series of 50 patients in classes II and III using the NYHA classification. 45 patients who had undergone cardiopulmonary testing were interviewed using a specially formulated questionnaire. They were also asked how far they could walk before being stopped by symptoms, and then tested on their ability to estimate distance.
The survey of cardiologists showed no consistent method for assessing NYHA class and a literature survey showed that 99% of research papers do not reference or describe their methods for assigning NYHA classes. The interoperator variability study showed only 54% concordance between the two cardiologists. 70% of cardiologists asked patients for their walk distance; however, this walk distance correlated poorly with actual exercise capacity measured by cardiopulmonary testing (rho = 0.04, p = 0.82).
No consistent method of assessing NYHA class is in use and the interoperator study on class II and class III patients gave a result little better than chance. Some potential questions are offered for use in assessment. Walking distance, although frequently asked, does not correlate with formally measured exercise capacity, even after correction for patient perception of distance, and has never been found to have prognostic relevance. Its value is therefore doubtful.
评估心力衰竭症状的两种方法是纽约心脏协会(NYHA)分级以及询问患者能够行走的距离(步行距离)。NYHA系统被广泛使用,尽管尚不清楚个体临床医生如何应用它。
研究这些测量方法在评估心力衰竭方面的有用性,以及其他问题是否可能更有帮助。
询问30位心脏病专家在评估心力衰竭患者时使用哪些问题。为评估操作者间的变异性,两位心脏病专家使用NYHA分级对50例II级和III级患者进行了评估。使用专门制定的问卷对45例接受过心肺测试的患者进行了访谈。还询问了他们在因症状而停止行走之前能够行走多远,然后测试了他们估计距离的能力。
对心脏病专家的调查显示,评估NYHA分级没有一致的方法,文献调查表明,99%的研究论文未提及或描述其分配NYHA分级的方法。操作者间变异性研究显示,两位心脏病专家之间的一致性仅为54%。70%的心脏病专家询问了患者的步行距离;然而,该步行距离与通过心肺测试测量的实际运动能力相关性较差(rho = 0.04,p = 0.82)。
目前没有一致的评估NYHA分级的方法,对II级和III级患者的操作者间研究结果仅略好于随机水平。提供了一些可能用于评估的问题。步行距离虽然经常被询问,但即使在纠正患者对距离的感知后,也与正式测量的运动能力无关,并且从未被发现具有预后相关性。因此其价值值得怀疑。